Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 November 2020 | Story Nonsidiso Qwabe | Photo Supplied

Acclaimed South African writer, author, and UFS research fellow Zubeida Jaffer was honoured with a lifetime achievement award for her career in journalism during the Standard Bank Sivukile Awards ceremony. 

Passion for journalism spans decades
During the award ceremony on 15 October 2020, Jaffer received the prestigious Allan Kirkland Soga Lifetime Achievement Award, which recognises a sustained and extraordinary contribution to journalism. Jaffer said she never chose journalism, but journalism chose her. She said when she first stepped into a newsroom looking for a holiday job in the 1970s, she did not know she had stepped into her future in news reporting. Since then, Jaffer has earned many accolades in the journalism industry as well as in academia. She also became an acclaimed author, and wrote her third book, Beauty of the Heart: The Life and Times of Charlotte Mannya Maxeke, during her time as a writer-in-residence at the UFS. While at the UFS, she founded the online media platform, The Journalist, a platform that provides history and context for key issues facing South African journalists. This portal also links students with academics across the country and will soon be extended to the African continent and the diaspora.

Jaffer said she felt blessed to be recognised among the many journalism pioneers in South Africa. 

“It’s extremely wonderful because it came so out of the blue. This year, with COVID-19, I was digging deep, and trying my best to keep focus. I’m very thankful. It’s made me pause, reflect, and realise that a lot of things I’ve done have been of value. When living your life, it’s not that you’re aware of that all the time. There are many people doing great things who don’t always get this kind of recognition,” Jaffer said.

Still a great need for journalists in South Africa 

Talking about journalism today, Jaffer said: “I am often overwhelmed to witness the enthusiasm and determination of young journalists across the country who come from humble backgrounds and inspire those around them. Our country is gripped in a bipolar condition. It is not clear how the healing will come, but it will. The challenge is to keep our minds in balance so that we can be strong enough to root out corruption and gender-based violence, while at the same time fully understanding our blessings as a people.”

UFS alumna Rising Star in Journalism 

In another accolade for the UFS, the Upcoming/Rising Star of the Year award went to former UFS Journalism student Brümilda Swartbooi for her article titled ‘Sy het hard vir ons gewerk’. The article highlighted the senseless killing of a woman outside her workplace, minutes after her husband dropped her off.

Brümilda Swartbooi. Photo: Supplied

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept